Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sarda

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Journal of Neuropathology and Experimental Neurology|August 14, 1999
Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissuesC Agulhon, P Blanchet, A Kobetz, et al.
Bone Marrow Transplantation|August 3, 2004
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosisA Altes, A F Remacha, P Sarda, et al.
Clinical Therapeutics|November 4, 2015
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III StudiesGavin Giovannoni, Ralf Gold, Robert J Fox, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 4, 2011
[Genetic syndromes that mimic congenital infections: report of 2 cases]M Thibault, J Leydet, E Tournier-Lasserve, et al.
Current Medical Research and Opinion|November 8, 2013
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparisonMichael Hutchinson, Robert J Fox, Eva Havrdova, et al.
Advances in Therapy|July 18, 2021
Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US PopulationWendy Y Cheng, Sujata P Sarda, Nikita Mody-Patel, et al.
Cytogenetic and Genome Research|November 13, 2013
Inverted segment size and the presence of recombination hot spot clusters matter in sperm segregation analysisS S Bhatt, M Manvelyan, K Moradkhani, et al.
Annals of Hematology|July 23, 2022
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS studyDavid Cella, Sujata P Sarda, Ray Hsieh, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 10, 2022
Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US PopulationWendy Y Cheng, Sujata P Sarda, Nikita Mody-Patel, et al.
Biology of the Neonate|March 30, 1999
Longitudinal multicentric study of plasma and red blood cell fatty acids and lipids in preterm newborns fed human milkF Babin, P Sarda, D Bouglé, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Journal of Neuropathology and Experimental Neurology|August 14, 1999
Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissuesC Agulhon, P Blanchet, A Kobetz, et al.
Bone Marrow Transplantation|August 3, 2004
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosisA Altes, A F Remacha, P Sarda, et al.
Clinical Therapeutics|November 4, 2015
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III StudiesGavin Giovannoni, Ralf Gold, Robert J Fox, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 4, 2011
[Genetic syndromes that mimic congenital infections: report of 2 cases]M Thibault, J Leydet, E Tournier-Lasserve, et al.
Current Medical Research and Opinion|November 8, 2013
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparisonMichael Hutchinson, Robert J Fox, Eva Havrdova, et al.
Advances in Therapy|July 18, 2021
Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US PopulationWendy Y Cheng, Sujata P Sarda, Nikita Mody-Patel, et al.
Cytogenetic and Genome Research|November 13, 2013
Inverted segment size and the presence of recombination hot spot clusters matter in sperm segregation analysisS S Bhatt, M Manvelyan, K Moradkhani, et al.
Annals of Hematology|July 23, 2022
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS studyDavid Cella, Sujata P Sarda, Ray Hsieh, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 10, 2022
Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US PopulationWendy Y Cheng, Sujata P Sarda, Nikita Mody-Patel, et al.
Biology of the Neonate|March 30, 1999
Longitudinal multicentric study of plasma and red blood cell fatty acids and lipids in preterm newborns fed human milkF Babin, P Sarda, D Bouglé, et al.
Pageof 15